These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 19283385)
1. Thoracic and abdominal MRA with gadofosveset: influence of injection rate on vessel signal and image quality. Nissen JC; Attenberger UI; Fink C; Dietrich O; Rohrer M; Schoenberg SO; Michaely HJ Eur Radiol; 2009 Aug; 19(8):1932-8. PubMed ID: 19283385 [TBL] [Abstract][Full Text] [Related]
2. Gadofosveset-enhanced magnetic resonance angiography of the thoracic vasculature in the equilibrium phase: feasibility and impact of dose. Kim CY; Heye T; Bashir MR; Gebhard TA; Merkle EM J Comput Assist Tomogr; 2013; 37(5):732-6. PubMed ID: 24045249 [TBL] [Abstract][Full Text] [Related]
3. Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T. Frydrychowicz A; Russe MF; Bock J; Stalder AF; Bley TA; Harloff A; Markl M Acad Radiol; 2010 Nov; 17(11):1394-400. PubMed ID: 20650665 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Power Versus Manual Injection in Bolus Shape and Image Quality on Contrast-Enhanced Magnetic Resonance Angiography: An Experimental Study in a Swine Model. Tsuboyama T; Jost G; Pietsch H; Tomiyama N Invest Radiol; 2017 Sep; 52(9):547-553. PubMed ID: 28448310 [TBL] [Abstract][Full Text] [Related]
5. First-pass and steady-state magnetic resonance angiography of the thoracic vasculature using gadofosveset trisodium. Naehle CP; Müller A; Willinek WA; Meyer C; Hestermann T; Gieseke J; Schild H; Thomas D J Magn Reson Imaging; 2009 Oct; 30(4):809-16. PubMed ID: 19787726 [TBL] [Abstract][Full Text] [Related]
6. Gain in signal-to-noise for first-pass contrast-enhanced abdominal MR angiography at 3 Tesla over standard 1.5 Tesla: prediction with a computer model. Merkle EM; Dale BM; Barboriak DP Acad Radiol; 2007 Jul; 14(7):795-803. PubMed ID: 17574130 [TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced whole-heart MR coronary angiography at 3.0 T using the intravascular contrast agent gadofosveset. Prompona M; Cyran C; Nikolaou K; Bauner K; Reiser M; Huber A Invest Radiol; 2009 Jul; 44(7):369-74. PubMed ID: 19554666 [TBL] [Abstract][Full Text] [Related]
8. Contrast Media in Time-Resolved MRA at 3T: A Systematic Quantitative and Qualitative Analysis of Concentration and Dose Effects on Image Parameters in Minipigs. Hadizadeh DR; Keil VC; Jost G; Pietsch H; Weibrecht M; Marx C; Willinek W Rofo; 2018 Aug; 190(8):747-757. PubMed ID: 30045399 [TBL] [Abstract][Full Text] [Related]
9. Congenital heart disease in adults: Quantitative and qualitative evaluation of IR FLASH and IR SSFP MRA techniques using a blood pool contrast agent in the steady state and comparison to first pass MRA. Febbo JA; Galizia MS; Murphy IG; Popescu A; Bi X; Turin A; Collins J; Markl M; Edelman RR; Carr JC Eur J Radiol; 2015 Oct; 84(10):1921-9. PubMed ID: 26253499 [TBL] [Abstract][Full Text] [Related]
10. Steady-state and dynamic MR angiography with MS-325: initial experience in humans. Grist TM; Korosec FR; Peters DC; Witte S; Walovitch RC; Dolan RP; Bridson WE; Yucel EK; Mistretta CA Radiology; 1998 May; 207(2):539-44. PubMed ID: 9577507 [TBL] [Abstract][Full Text] [Related]
11. Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR-angiography at 3.0 tesla: Effects of contrast bolus length and flip angle. Schubert T; Motosugi U; Kinner S; Colgan TJ; Sharma SD; Hetzel S; Wells S; Campo CA; Reeder SB J Magn Reson Imaging; 2017 Jun; 45(6):1617-1626. PubMed ID: 27862577 [TBL] [Abstract][Full Text] [Related]
12. Part 2 - Coronary angiography with gadofosveset trisodium: a prospective intra-subject comparison for dose optimization for 100 % efficiency imaging. Ahlman MA; Raman FS; Pang J; Zemrak F; Sandfort V; Penzak SR; Fan Z; Liu S; Li D; Bluemke DA BMC Cardiovasc Disord; 2016 Mar; 16():58. PubMed ID: 27004532 [TBL] [Abstract][Full Text] [Related]
13. [Systematic analysis of the geometry of a defined contrast medium bolus--implications for contrast enhanced 3D MR-angiography of thoracic vessels]. Kreitner KF; Kunz RP; Weschler C; Ley S; Krummenauer F; Schreiber WG; Thelen M Rofo; 2005 May; 177(5):646-54. PubMed ID: 15871079 [TBL] [Abstract][Full Text] [Related]
14. Intraindividual quantitative and qualitative comparison of gadopentetate dimeglumine and gadobutrol in time-resolved contrast-enhanced 4-dimensional magnetic resonance angiography in minipigs. Hadizadeh DR; Jost G; Pietsch H; Weibrecht M; Perkuhn M; Boschewitz JM; Keil VC; Träber F; Kukuk GM; Schild HH; Willinek WA Invest Radiol; 2014 Jul; 49(7):457-64. PubMed ID: 24598442 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of four injection profiles for uniform contrast-enhanced signal intensity profiles in MR angiography. Maki JH; Wilson GJ; Clark TJ J Magn Reson Imaging; 2019 Dec; 50(6):1808-1816. PubMed ID: 31095810 [TBL] [Abstract][Full Text] [Related]
16. Arterial-phase three-dimensional gadolinium magnetic resonance angiography of the renal arteries. Strategies for timing and contrast media injection: original investigation. Schoenberg SO; Knopp MV; Prince MR; Londy F; Knopp MA Invest Radiol; 1998 Sep; 33(9):506-14. PubMed ID: 9766034 [TBL] [Abstract][Full Text] [Related]
17. A comparison between gadofosveset trisodium and gadobenate dimeglumine for steady state MRA of the thoracic vasculature. Camren GP; Wilson GJ; Bamra VR; Nguyen KQ; Hippe DS; Maki JH Biomed Res Int; 2014; 2014():625614. PubMed ID: 25061611 [TBL] [Abstract][Full Text] [Related]
18. Effect of Contrast Agent Dose Reduction on Vascular Enhancement and Image Quality in Thoracoabdominal Dynamic 3-Dimensional Magnetic Resonance Angiography: A Systematic Intraindividual Analysis in Pigs. Endler CH; Jost G; Pietsch H; Luetkens JA; Keil VC; Willinek WA; Attenberger UI; Hadizadeh DR Invest Radiol; 2022 Oct; 57(10):689-695. PubMed ID: 35510876 [TBL] [Abstract][Full Text] [Related]